Cephalexin-d5 (hydrate)

Cephalexin-d5 (hydrate)

• UNSPSC Description: Cephalexin-d5 (hydrate) is deuterium labeled Cephalexin (monohydrate). Cephalexin (Cefalexin) monohydrate is a potent, orally active new semisynthetic cephalosporin antibiotic with a broad antibacterial spectrum. Cephalexin (Cefalexin) monohydrate has antibacterial activity against a wide variety of gram-positive and gram-negative bacteria. Cephalexin (Cefalexin) monohydrate targets penicillin-binding proteins (PBPs) to inhibit bacterial cell wall assembly. Cephalexin (Cefalexin) monohydrate is used for the research of pneumonia, strep throat, and bacterial endocarditis, et al[1][2][3].
• Target Antigen: Antibiotic; Bacterial; Isotope-Labeled Compounds; Penicillin-binding protein (PBP)
• Type: Reference compound
• Related Pathways: Anti-infection;Others
• Field of Research: Cancer
• Smiles: N[C@H](C1=C(C([2H])=C(C([2H])=C1[2H])[2H])[2H])C(N[C@@H]2C(N3C2SCC(C)=C3C(O)=O)=O)=O.O
• Molecular Weight: 370.43
• References & Citations: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.|[2]Cho H, et, al. Beta-lactam antibiotics induce a lethal malfunctioning of the bacterial cell wall synthesis machinery. Cell. 2014 Dec 4;159(6):1300-11. |[3]Buck RE, et, al. Cefadroxil, a new broad-spectrum cephalosporin. Antimicrob Agents Chemother. 1977 Feb;11(2):324-30.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported